메뉴 건너뛰기




Volumn 383, Issue 9914, 2014, Pages 305-306

Authors' reply

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; MEDROXYPROGESTERONE ACETATE; DRUG DERIVATIVE; NORETHISTERONE;

EID: 84892844932     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/s0140-6736(14)60100-8     Document Type: Letter
Times cited : (4)

References (6)
  • 1
    • 84886793400 scopus 로고    scopus 로고
    • Next steps for research on hormonal contraception and HIV
    • Ralph LJ, McCoy SI, Hallett T, Padian N. Next steps for research on hormonal contraception and HIV. Lancet 2013; 382: 1467-69.
    • (2013) Lancet , vol.382 , pp. 1467-1469
    • Ralph, L.J.1    McCoy, S.I.2    Hallett, T.3    Padian, N.4
  • 2
    • 41649108404 scopus 로고    scopus 로고
    • Hormonal contraception and the risks of STI acquisition: Results of a feasibility study to plan a future randomized trial
    • Hubacher D, Raymond ER, Beksinka, et al. Hormonal contraception and the risks of STI acquisition: results of a feasibility study to plan a future randomized trial. Contraception 2008; 77: 366-70.
    • (2008) Contraception , vol.77 , pp. 366-370
    • Hubacher, D.1    Raymond, E.R.2    Beksinka3
  • 3
    • 23644434606 scopus 로고    scopus 로고
    • Randomized assignment to copper IUD or depot-medroxyprogesterone acetate: Feasibility of enrollment, continuation, and disease ascertainment
    • Feldblum PJ, Caraway J, Bahamondes L, et al. Randomized assignment to copper IUD or depot-medroxyprogesterone acetate: feasibility of enrollment, continuation, and disease ascertainment. Contraception 2005; 72: 187-91.
    • (2005) Contraception , vol.72 , pp. 187-191
    • Feldblum, P.J.1    Caraway, J.2    Bahamondes, L.3
  • 4
    • 34547606191 scopus 로고    scopus 로고
    • A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus
    • Stringer EM, Kaseba C, Levy J, et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol 2007; 197: 144.e1-e8.
    • (2007) Am J Obstet Gynecol , vol.197
    • Stringer, E.M.1    Kaseba, C.2    Levy, J.3
  • 5
    • 77949363499 scopus 로고    scopus 로고
    • Weighing the gold in the gold standard: Challenges in HIV prevention research
    • Padian NS, McCoy SI, Balkus JE, Wasserhiet JN. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS 2010; 24: 621-35.
    • (2010) AIDS , vol.24 , pp. 621-635
    • Padian, N.S.1    McCoy, S.I.2    Balkus, J.E.3    Wasserhiet, J.N.4
  • 6
    • 84862849188 scopus 로고    scopus 로고
    • Pre-exposure prophylaxis for HIV prevention: How to predict success
    • Kashuba AD, Patterson KB, Dumond JB, Cohen MS. Pre-exposure prophylaxis for HIV prevention: how to predict success. Lancet 2012; 379: 2409-11.
    • (2012) Lancet , vol.379 , pp. 2409-2411
    • Kashuba, A.D.1    Patterson, K.B.2    Dumond, J.B.3    Cohen, M.S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.